The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.50
Bid: 50.20
Ask: 50.60
Change: -0.20 (-0.40%)
Spread: 0.40 (0.797%)
Open: 49.50
High: 49.50
Low: 49.50
Prev. Close: 49.70
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

8 Jan 2024 17:20

RNS Number : 0067Z
IP Group PLC
08 January 2024
 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited (which is trading for these purposes as Deutsche Numis) ("Deutsche Numis"), purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 18th December 2023 (the Buyback Programme).

Date of purchase:

08/01/2024

Number of ordinary shares purchased:

47,841

Highest price paid per ordinary share (GBp):

55.30

Lowest price paid per ordinary share (GBp): 

54.20

Volume weighted average price paid per ordinary share (GBp): 

54.8889

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 26,717,415 of its ordinary shares in treasury and has 1,063,188,005 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,036,470,590 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Deutsche Numis on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

08/01/2024

Number of ordinary shares purchased:

47,841

Volume weighted average price (pence):

54.8889

 

 

Individual transactions:

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Trading venue

1182

54.80

 09:19:30

XLON

159

54.60

 09:23:34

XLON

43

54.50

 09:24:44

XLON

38

54.50

 09:29:28

XLON

568

54.50

 09:29:28

XLON

411

54.40

 09:29:29

XLON

368

54.40

 09:29:29

XLON

43

54.40

 09:29:29

XLON

145

54.40

 09:29:29

XLON

531

54.40

 09:29:29

XLON

308

54.40

 09:29:29

XLON

713

54.20

 09:32:53

XLON

502

54.20

 09:32:53

XLON

2051

54.40

 11:30:30

XLON

196

54.40

 11:30:30

XLON

3162

54.40

 11:30:30

XLON

542

54.30

 11:30:31

XLON

1751

54.30

 11:30:41

XLON

574

54.30

 11:30:41

XLON

426

54.30

 11:30:41

XLON

475

54.40

 11:59:35

XLON

2709

54.40

 11:59:35

XLON

1201

54.20

 12:22:42

XLON

224

54.20

 12:22:42

XLON

23

54.20

 12:22:42

XLON

200

54.20

 12:22:42

XLON

223

54.20

 12:22:42

XLON

10

54.20

 12:22:42

XLON

181

55.00

 13:37:19

XLON

1625

55.30

 14:40:02

XLON

2168

55.30

 14:40:02

XLON

524

55.10

 14:42:58

XLON

286

55.10

 14:42:58

XLON

25

55.10

 14:42:58

XLON

346

55.10

 14:42:58

XLON

1003

55.10

 14:42:58

XLON

356

55.20

 15:26:34

XLON

2324

55.20

 15:32:44

XLON

888

55.20

 15:32:44

XLON

474

55.20

 15:32:45

XLON

1097

55.30

 15:32:52

XLON

591

55.30

 15:32:52

XLON

15

55.30

 15:34:09

XLON

1520

55.30

 15:34:09

XLON

42

55.20

 15:41:56

XLON

377

55.30

 15:42:31

XLON

458

55.30

 15:42:31

XLON

2118

55.20

 15:47:35

XLON

6

55.20

 15:47:35

XLON

32

55.20

 15:56:42

XLON

166

55.20

 16:05:16

XLON

398

55.20

 16:05:16

XLON

417

55.20

 16:05:16

XLON

700

55.20

 16:05:16

XLON

786

55.20

 16:05:16

XLON

699

55.20

 16:05:16

XLON

1401

55.10

 16:09:31

XLON

153

55.10

 16:09:35

XLON

1887

55.10

 16:09:35

XLON

323

55.10

 16:15:36

XLON

1177

55.20

 16:20:14

XLON

848

55.20

 16:20:14

XLON

3652

55.30

 16:20:14

XLON

 

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Vic Wallin

+44 (0) 7973 823119

Alex Donaldson

+44 (0) 7516 729702

 

Further information on IP Group is available on our website: www.ipgroupplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMZGGMNRLGDZM
Date   Source Headline
17th Jun 20217:00 amRNSPortfolio company Apollo Therapeutics raises $145m
15th Jun 20218:00 amRNSFurther re Scrip Dividend
9th Jun 202111:29 amRNSResult of AGM
9th Jun 20217:00 amRNSAGM Statement
7th Jun 20217:00 amRNSPortfolio co Iksuda completes $42m financing round
28th May 20213:36 pmRNSDirector/PDMR Shareholding
28th May 202110:00 amRNSJoint venture with China Everbright to launch fund
27th May 20217:00 amRNSPortfolio co Pulmocide completes $92m Series C
26th May 20212:44 pmRNSUpdate on AGM
20th May 202110:01 amRNSScrip Dividend Reference Price
17th May 202112:44 pmRNSAdditional fair value gain of £20m
12th May 202112:08 pmRNSHolding(s) in Company
10th May 202111:15 amRNSInvestor webinars
6th May 20216:13 pmRNSNotice of AGM, Annual Report, Scrip Dividend
6th May 20215:55 pmRNSLTIP & DBSP awards; Director/PDMR shareholding
5th May 20217:00 amRNSPortfolio company Kuur acquired by Athenex
5th May 20217:00 amRNSPortfolio company Inivata acquired by NeoGenomics
4th May 20217:00 amRNSPortfolio company Oxford Nanopore raises £195m
7th Apr 202111:27 amRNSDirector/PDMR Shareholding
31st Mar 20219:15 amRNSHolding(s) in Company
30th Mar 20217:05 amRNSOxford Nanopore announces preparing for IPO in H2
26th Mar 202112:26 pmRNSEMA positive opinion for Diurnal's Chronocort
10th Mar 20217:00 amRNSAnnual Results
4th Mar 20216:07 pmRNSHolding(s) in Company
2nd Mar 202112:03 pmRNSHolding(s) in Company
24th Feb 202110:33 amRNSNotice of Results
18th Feb 20214:31 pmRNSHolding(s) in Company
18th Feb 20218:00 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSPortfolio company ApcinteX acquired by Centessa
10th Feb 20217:00 amRNSIP Group, Inc. raises $50.0m (£36.5m*) of funding
9th Feb 20213:52 pmRNSHolding(s) in Company
2nd Feb 20215:15 pmRNSHolding(s) in Company
11th Jan 20215:29 pmRNSHolding(s) in Company
6th Jan 20214:57 pmRNSPortfolio co Hinge Health completes $300m round
6th Jan 202111:34 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSPortfolio co Oxbotica completes £36m funding round
4th Dec 202011:41 amRNSHolding(s) in Company
3rd Dec 20208:01 amRNSArtios and Merck in global strategic collaboration
25th Nov 20207:00 amRNSDirector Declaration
23rd Nov 20205:05 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSInvestor webinar
13th Oct 20207:00 amRNSOxford Nanopore funding round and contract win
9th Oct 20209:46 amRNSOxford Nanopore's LamPORE test gains CE-IVD mark
7th Oct 20207:00 amRNSEnterprise Therapeutics' program acquired by Roche
23rd Sep 20201:40 pmRNSHolding(s) in Company
15th Sep 202012:07 pmRNSSecond Price Monitoring Extn
15th Sep 202012:02 pmRNSPrice Monitoring Extension
7th Sep 202012:07 pmRNSSecond Price Monitoring Extn
7th Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20205:18 pmRNSForm 8.3 - Modern Water plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.